NCT03932110 Metabolic Syndrome in Psoriasis and Psoriatic Arthritis and Correlation With Serum Omentin and Visfatin Levels Status COMPLETED Phase NA
NCT03926195 Study to Evaluate the Effect of Filgotinib on Semen Parameters in Adult Males With Active Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, or Non-radiographic Axial Spondyloarthritis Status COMPLETED Phase PHASE2
NCT03896581 A Study to Evaluate the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis Status COMPLETED Phase PHASE3
NCT03895203 A Study to Test the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis Status COMPLETED Phase PHASE3
NCT03835780 The Risk of Venous Thromboembolism in Systemic Inflammatory Disorders: a United Kingdom (UK) Matched Cohort Study Status COMPLETED Phase N/A
NCT03816917 Discovery of Arthritis in Psoriasis Patients for Early Rheumatological Referral Status COMPLETED Phase N/A
NCT03816345 Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO Status RECRUITING Phase PHASE1
NCT03797872 Psoriatic Oligoarthritis Intervention With Symptomatic thErapy Status COMPLETED Phase PHASE4
NCT03783026 A Study to Evaluate the Impact of Apremilast on Magnetic Resonance Imaging (MRI) Outcomes in Adults With Psoriatic Arthritis Status COMPLETED Phase PHASE4
NCT03780504 Apremilast in Psoriatic Arthritis in Real-life Clinical Practice in Greece Status UNKNOWN Phase N/A
NCT03739853 Severe Psoriatic Arthritis - Early intervEntion to Control Disease: the SPEED Trial Status COMPLETED Phase PHASE4
NCT03736161 Safety and Efficacy of Tofacitinib vs Methotrexate in the Treatment of Psoriatic Arthritis Status COMPLETED Phase PHASE3
NCT03693833 CBD Treatment in Hand Osteoarthritis and Psoriatic Arthritis. Status COMPLETED Phase PHASE2
NCT03675308 A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Have a History of Inadequate Response to or Intolerance to at Least One Disease Modifying Anti-Rheumatic Drug (DMARD) Therapy Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03626038 Post Market Clinical Follow-up (PMCF) Study of the A.L.P.S. Proximal Humerus Plating System Status ACTIVE_NOT_RECRUITING Phase NA